文献リスト

1）Louis DN, Ohgaki H, Wiestler OD, et al. World Health Organization Classification of Tumours of the Central Nervous System. 4th ed. Lyon: International Agency for Research on Cancer; 2007

2）Pekmezci M, Louie J, Gupta N, et al. Clinicopathological characteristics of adamantinomatous and papillary craniopharyngiomas: University of California, San Francisco experience 1985-2005. Neurosurgery. 2010; 67: 1341-9

3）Müller HL. Childhood craniopharyngioma. Pituitary. 2013; 16: 56-67

4）Fahlbusch R, Honegger J, Paulus W, et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg. 1999; 90: 237-50

5）Hoffman HJ, De Silva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992; 76: 47-52

6）後藤剛夫，國廣誉世，森迫拓貴，他．頭蓋咽頭腫に対する手術到達法選択の重要性．脳神経外科ジャーナル．2014; 23: 12-9

7）Kunihiro N, Goto T, Ishibashi K, et al. Surgical outcomes of the minimum anterior and posterior combined transpetrosal approach for resection of retrochiasmatic craniopharyngiomas with complicated conditions. J Neurosurg. 2014; 120: 1-11

8）Warmuth-Metz M, Gnekow AK, Muller H, et al. Differential diagnosis of suprasellar tumors in children. Klin Padiatr. 2004; 216: 323-30

9）Shi XE, Wu B, Fan T, et al. Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg. 2008; 110: 151-9

10）Bartels U, Laperriere N, Bouffet E, et al. Intracystic therapies for cystic craniopharyngioma in childhood. Front Endocrinol (Lausanne). 2012; 3: 39

11）Cavalheiro S, Dastoli PA, Silva NS, et al. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst. 2005; 21: 719-24

12）Liu W, Fang Y, Cai B, et al. Intracystic bleomycin for cystic craniopharyngiomas in children. Neurosurgery. 2012; 71: 909-15

13）Steinbok P, Hukin J. Intracystic treatments for craniopharyngioma. Neurosurg Focus. 2010; 28: E13

14）Di Rocco C, Caldarelli M, Tamburrini G, et al. Surgical management of craniopharyngiomas experience with a pediatric series. J Pediatr Endocrinol Metab. 2006; 19: 355-66

15）Duff JM, Meyer FB, Ilstrup DM, et al. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery. 2000; 46: 291-302

16）Hofmann BM, Hollig A, Strauss C, et al. Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997. J Neurosurg. 2012; 116: 373-84

17）Kim EH, Ahn JY, Kim SH. Technique and outcome of endoscopy-assisted microscopic extended transsphenoidal surgery for suprasellar craniopharyngiomas. J Neurosurg. 2011; 114: 1338-49

18）Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg. 2002; 97: 3-11

19）Yamada S, Fukuhara N, Oyama K, et al. Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery. World Neurosurg. 2010; 74: 320-30

20）Elliott RE, Jane JA Jr, Wisoff JH. Surgical management of craniopharyngiomas in children: meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurgery. 2011; 69: 630-43

21）Caldarelli M, Massimi L, Tamburrini G, et al. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome. Childs Nerv Syst. 2005; 21: 747-57

22）Chakrabarti I, Amar AP, Couldwell W, et al. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma. J Neurosurg. 2005; 102: 650-7

23）Leng LZ, Greenfield JP, Souweidane MM, et al. Endoscopic, endonasal resection of craniopharyngiomas: analysis of outcome including extent of resection, cerebrospinal fluid leak, return to preoperative productivity, and body mass index. Neurosurgery. 2012; 70: 110-23

24）Maira G, Anile C, Albanese A, et al. The role of transsphenoidal surgery in the treatment of craniopharyngiomas. J Neurosurg. 2004; 100: 445-51

25）Komotar RJ, Starke RM, Raper DM, et al. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg. 2012; 77: 329-41

26）Yasargil MG, Curcic M, Kis M, et al. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg. 1990; 73: 3-11

27）Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol. 2004; 46: 220-9

28）Muller HL, Emser A, Faldum A, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004; 89: 3298-305

29）Srinivasan S, Ogle GD, Garnett SP, et al. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab. 2004; 89: 81-6

30）Holmer H, Ekman B, Bjork J, et al. Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy. Eur J Endocrinol Eur Fed Endocr Soc. 2009; 161: 671-9

31）Mong S, Pomeroy SL, Cecchin F, et al. Cardiac risk after craniopharyngioma therapy. Pediatr Neurol. 2008; 38: 256-60

32）Pereira AM, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol. 2005; 62: 197-204

33）Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: the St. Jude Childrenʼs research hospital experience 1984-2001. Int J Radiat Oncol Biol Phys. 2002; 53: 533-42

34）Crom D, Smith D, Xiong Z, et al. Health status in long-term survivors of pediatric craniopharyngiomas. Am Assoc Neurosci Nurses. 2010; 42: 323-8

35）Geffner M, Lundberg M, Koltowska-Haggstrom M, et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metabol. 2004; 89: 5435-40

36）Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst. 2005; 21: 640-8

37）Saleem MA, Hashim AS, Rashid A, et al. Role of gamma knife radiosurgery in multimodality management of craniopharyngioma. Acta Neurochir Suppl. 2013; 116: 55-60

38）Chiou SM, Lunsford LD, Niranjan A, et al. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neuro Oncol. 2001; 3: 159-66

39）Iwata H, Tatewaki K, Inoue M, et al. Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma. J Neurooncol. 2012; 106: 571-7

40）Kanesaka N, Mikami R, Nakayama H, et al. Preliminary results of fractionated radiotherapy after cyst drainage for craniopharyngioma in adults. Int J Radiat Oncol Biol Phys. 2012; 82: 1356-60

41）Kobayashi T, Kida Y, Mori Y, et al. Long-term results of gamma knife surgery for treatment of craniopharyngioma in 98 consecutive cases. J Neurosurg Pediatr. 2005; 103: 482-8

42）Masson-Cote L, Masucci GL, Atenafu EG, et al. Long-term outcomes for adult craniopharyngioma following radiation therapy. Acta Oncol. 2013; 52: 153-8

43）Minniti G, Saran F, Traish D, et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother Oncol. 2007; 82: 90-5

44）Niranjan A, Kano H, Mathieu D, et al. Radiosurgery for craniopharyngioma. Int J Radiat Oncol Biol Phys. 2010; 78: 64-71

45）Schulz-Ertner D, Frank C, Herfarth KK, et al. Fractionated stereotactic radiotherapy for craniopharyngioma. Int J Radiat Oncol Biol Phys. 2002; 54: 1114-20

46）Xu Z, Yen CP, Schlesinger D, et al. Outcomes of gamma knife surgery for craniopharyngioma. J Neurooncol. 2011; 104: 305-13

47）Habrand JL, Ganry O, Couanet D, et al. The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys. 1999; 44: 255-63

48）Merchant TE, Kun LE, Hua CH, et al. Disease control after reduced volume conformal and intensity modulated radiation therapy for childhood craniopharyngioma. Int J Radiat Oncol Biol Phys. 2013; 85: 187-92

49）Moussa AH, Kerasha AA, Mahmoud ME. Surprising outcome of ommaya reservoir in treating cystic craniopharyngioma: a retrospective study. Br J Neurosurg. 2013; 27: 370-3

50）Cho WS, Kim SK, Wang KC, et al. Vasculopathy after intracystic bleomycin administration for a recurrent cystic craniopharyngioma: case report. J Neurosurg Pediatr. 2012; 9: 394-9

51）Yeung JT, Pollack IF, Panigrahy A, et al. Pegylated interferon-α-2b for children with recurrent craniopharyngioma. J Neurosurg Pediatr. 2012; 10: 498-503

52）Ierardi DF, Fernandes MJ, Silva IR, et al. Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas. Childs Nerv Syst. 2007; 23: 1041-6

53）Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf). 2005; 62: 397-409

54）Mortini P, Losa M, Pozzobon G, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011; 114: 1350-9

55）Lee MH, Kim SH, Seoul HJ, et al. Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas. J Clin Neurosci. 2012; 19: 1005-8

56）Smee RI, Williams JR, Kwok B, et al. Modern radiotherapy approaches in the management of craniopharyngiomas. J Clin Neurosci. 2011; 18: 613-7

57）Zygourakis CC, Kaur G, Kunwar S, et al. Modern treatment of 84 newly diagnosed craniopharyngiomas. J Clin Neurosci. 2014; 21: 1558-66

58）Yang I, Sughrue ME, Rutkowski MJ, et al. Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus. 2010; 28: E5

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp